Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study

Abstract Purpose  The aim of this study was to investigate the combination of vinorelbine (VRL) alternating intravenous (i.v.) and oral in combination with docetaxel (DCT) as first-line chemotherapy of patients with metastatic breast cancer.